PTPN22 not only altered the composition of immune cells in the TME (Figure S1B), promoting Tregs and macrophage infiltration, but further analysis also revealed a positive correlation between PTPN22 expression and Tumor Immune Dysfunction and Rejection (TIDE) immune dysfunction scores (Figure 1C). Here, PTPN22 is linked to neoplasm.